LECO vs RVTY vs TMO Stock Comparison

Lincoln Electric Holdings, Revvity and Thermo Fisher Scientific Prices as of Nov 2, 2026 Peers: Industry group
1 more company in this comparison (ESAB) Create a free account to keep reading and compare up to 10 companies.
RVTY Revvity, Inc.
$151.70 +0.1% 1M +62.1% 1Y
Market cap
$16.93B
P/E
71.3x
Revenue (TTM)
$2.91B
Div. yield
0.18%
Life Sciences Tools Healthcare
1 win

Head to Head

12 decided of 12

Lincoln Electric Holdings leads on 7 of the 12 questions below (Lincoln Electric Holdings 7, Thermo Fisher Scientific 4, Revvity 1). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionLECORVTYTMOLeader
Larger companyMarket capitalisation $15.46B $16.93B $252.45B TMO
Cheaper on earningsLower P/E, profitable companies only 27.0x 71.3x 35.8x LECO
Cheaper on forward earningsLower price / next fiscal year consensus EPS 24.6x 29.7x 26.4x LECO
Faster revenue growthRevenue growth, trailing twelve months +11.1% +4.1% +8.3% LECO
More profitableNet margin, trailing twelve months 12.4% 8.2% 14.9% TMO
Better return on capitalReturn on invested capital 22.6% 3.1% 8.0% LECO
Less leveragedLower net debt / EBITDA 1.0x 2.8x 3.1x LECO
Higher dividend yieldTrailing dividend yield 1.11% 0.18% 0.27% LECO
Better 1-year returnPrice return, last 12 months +21.8% +62.1% +20.3% RVTY
Better 5-year returnAnnualised price return, 5 years +15.1%/yr -2.7%/yr +1.2%/yr LECO
Less volatileAnnualised volatility, 1 year 31.1% 40.1% 30.0% TMO
Higher overall scoreMean of the five percentile scores vs peers 55/100 58/100 59/100 TMO

Percentile Scorecard

LECORVTYTMO

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisLECORVTYTMO
Valuation 35 #133 of 203 71 #67 of 227 60 #91 of 227
Growth 46 #102 of 189 27 #160 of 220 39 #135 of 220
Profitability 93 #14 of 187 80 #43 of 209 83 #36 of 209
Financial Health 46 #121 of 221 47 #127 of 240 31 #166 of 240
Shareholder Returns 55 #69 of 152 64 #50 of 138 83 #25 of 138
Overall 55 58 59
  • LECO ranked among 223 companies in Machinery
  • RVTY ranked among 247 companies in Medical Devices and Diagnostics
  • TMO ranked among 247 companies in Medical Devices and Diagnostics

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodLECORVTYTMOSPY
1 month +4.1%+0.1%+4.2% -2.3%
3 months +6.6%+31.7%+18.9% -0.7%
6 months +8.9%+75.4%+47.6% +4.8%
Year to date +19.1%+56.8%+17.8% +10.3%
1 year +21.8%+62.1%+20.3% +10.3%
3 years +55.2%+72.1%+50.1% +73.0%
3 years, per year +15.8%+19.8%+14.5% +20.1%
5 years +101.9%-12.9%+6.3% +61.9%
5 years, per year +15.1%-2.7%+1.2% +10.1%
10 years +349.3%+203.3%+368.3% +258.6%
10 years, per year +16.2%+11.7%+16.7% +13.6%

Risk

MeasureLECORVTYTMOSPY
Volatility, 1Y 31.1%40.1%30.0% 12.8%
Downside volatility, 1Y 31.4%36.6%28.6% 12.8%
Beta vs S&P 500, 1Y 1.191.250.63 1.00
Return / volatility, 1Y 0.701.550.68 0.80
Max drawdown, 5Y -35.3%-59.2%-41.5% -25.4%
From 52-week high -4.5%-8.5%-3.7% -3.5%
52-week high $298.88$165.78$709.29 $779.14
52-week low $220.64$82.26$438.34 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleLECORVTYTMO
P/E now vs peer median 27.0xmedian 25.6x 71.3xmedian 28.4x 35.8xmedian 28.4x
P/S now vs peer median 3.3xmedian 1.9x 5.8xmedian 3.0x 5.3xmedian 3.0x
EV/EBITDA now vs peer median 18.0xmedian 14.4x 24.6xmedian 18.0x 24.9xmedian 18.0x
P/FCF now vs peer median 30.2xmedian 22.5x 29.8xmedian 25.0x 33.2xmedian 25.0x
P/B now vs peer median 9.9xmedian 2.2x 2.3xmedian 2.3x 4.6xmedian 2.3x
PEG now vs peer median 3.87median 1.36 -2.29median 0.93 4.73median 0.93

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsLECORVTYTMO
Revenue $4.64B $2.91B $47.35B
Gross profit $1.65B $1.60B $19.45B
Operating income $802.52M $358.85M $8.47B
Net income $575.27M $237.55M $7.09B
Free cash flow $511.89M $568.85M $7.60B
R&D – $215.83M $1.40B
EPS (diluted) $10.48 $2.13 $19.06
Cash & equivalents $283.24M $1.02B $5.46B
Total debt $1.15B $3.21B $41.37B
Shares (diluted) 54.87M 111.63M 371.00M
Enterprise value $14.33B $13.19B $229.09B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricLECORVTYTMO
P/E 27.0x 71.3x 35.8x
P/FCF 30.2x 29.8x 33.2x
P/Operating cash flow 23.2x 26.5x 27.1x
P/S 3.3x 5.8x 5.3x
P/B 9.9x 2.3x 4.6x
P/Tangible book 9.9x 3.4x 6.9x
EV/EBITDA 18.0x 24.6x 24.9x
EV/EBIT 20.3x 53.3x 34.0x
EV/Revenue 3.5x 6.6x 6.1x
EV/FCF 31.9x 33.6x 37.9x
EV/Operating cash flow 24.5x 29.9x 30.9x
PEG (3Y EPS CAGR) 3.87 -2.29 4.73

Growth

14 metrics
MetricLECORVTYTMO
Revenue growth (1Y) 11.1% 4.1% 8.3%
Revenue CAGR (3Y) 4.5% 0.9% 2.9%
Gross profit growth (1Y) 7.7% 2.3% 7.8%
Gross profit CAGR (3Y) 5.5% -0.4% 4.0%
Operating income growth (1Y) 12.9% -5.5% 12.8%
Operating income CAGR (3Y) 7.0% -3.7% 7.2%
Net income growth (1Y) 9.6% -16.7% 7.9%
Net income CAGR (3Y) 4.9% -33.8% 6.2%
EPS growth (1Y) 11.0% -12.3% 9.7%
EPS CAGR (3Y) 7.0% -31.2% 7.6%
Operating cash flow growth (1Y) 0.7% 6.2% 21.9%
Operating cash flow CAGR (3Y) 0.5% 86.9% 4.5%
Free cash flow growth (1Y) -6.3% 9.5% 24.3%
Free cash flow CAGR (3Y) -3.6% 64.8% 5.1%

Profitability

14 metrics
MetricLECORVTYTMO
Gross margin 35.5% 55.0% 41.1%
EBITDA margin 19.5% 26.6% 24.4%
Operating margin 17.3% 12.3% 17.9%
Pretax margin 16.2% 9.0% 16.7%
Net margin 12.4% 8.2% 14.9%
FCF margin 11.0% 19.5% 16.0%
Operating cash flow margin 14.4% 21.9% 19.7%
Return on equity 37.0% 3.3% 13.2%
Return on assets 14.9% 2.0% 6.2%
Return on invested capital 22.6% 3.1% 8.0%
Return on capital employed 27.7% 3.3% 8.5%
Asset turnover 1.2x 0.2x 0.4x
Cash conversion (OCF / net income) 1.2x 2.7x 1.3x
Stock comp / revenue 0.5% 0.8% 0.7%

Financial Health

11 metrics
MetricLECORVTYTMO
Debt / assets 29.5% 26.6% 36.2%
Debt / equity 0.7x 0.4x 0.8x
Net debt / EBITDA 1.0x 2.8x 3.1x
Debt / FCF 2.2x 5.6x 5.4x
Liabilities / assets 60.1% 40.0% 52.1%
Equity / assets 39.9% 60.0% 47.9%
Interest coverage – 3.7x 5.5x
Current ratio 1.9x 1.8x 1.8x
Quick ratio 1.0x 1.4x 1.2x
Cash ratio 0.3x 0.8x 0.4x
Altman Z-score 7.78 3.26 4.11

Shareholder Returns

7 metrics
MetricLECORVTYTMO
Dividend yield 1.1% 0.2% 0.3%
Net buyback yield 1.8% 2.8% 1.6%
Shareholder yield 2.9% 3.0% 1.9%
Payout ratio (earnings) 30.0% 13.4% 9.5%
Payout ratio (FCF) 33.7% 5.6% 8.9%
Dividend growth (1Y) 3.5% -6.3% 8.0%
Dividend CAGR (3Y) 6.3% -6.1% 10.1%

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusLECORVTYTMO
Forward P/E 24.6xFY2026 29.7xFY2026 26.4xFY2026
EPS, next fiscal year $11.62FY2026 $5.10FY2026 $25.91FY2026
EPS growth, next FY +17.7%FY2026 +0.8%FY2026 +13.3%FY2026
EPS growth, the year after +0.4% +11.0% +2.0%
Revenue, next fiscal year $4.84BFY2026 $2.98BFY2026 $50.12BFY2026
Revenue growth, next FY +14.5%FY2026 +4.0%FY2026 +12.5%FY2026
Revenue growth, the year after +5.5% -2.0% -2.8%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersLECORVTYTMO
Held by institutions 81.3% 100.0% 90.2%
Institutions holding 703 547 2,625
Change in shares held, QoQ +5.5% -1.3% +0.8%
Institutions buying 299 303 1,144
Institutions selling 266 161 1,145
Buyers to sellers 1.12 1.88 1.00

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

LECORVTYTMO
LECO 1.00 0.34 0.21
RVTY 0.34 1.00 0.71
TMO 0.21 0.71 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, LECO, RVTY and TMO?

Thermo Fisher Scientific (TMO) is the largest by market capitalisation: Lincoln Electric Holdings (LECO) $15.46B, Revvity (RVTY) $16.93B, Thermo Fisher Scientific (TMO) $252.45B.

Which stock is cheaper, LECO, RVTY and TMO?

Lincoln Electric Holdings (LECO) trades on the lowest price-to-earnings ratio (Lincoln Electric Holdings (LECO) 27.0x, Revvity (RVTY) 71.3x, Thermo Fisher Scientific (TMO) 35.8x). On next year's consensus earnings, Lincoln Electric Holdings (LECO) is cheapest (Lincoln Electric Holdings (LECO) 24.6x, Revvity (RVTY) 29.7x, Thermo Fisher Scientific (TMO) 26.4x). A lower multiple can reflect slower expected growth, so read it next to the growth figures.

Which company is growing faster?

Lincoln Electric Holdings (LECO) grew revenue fastest over the trailing twelve months: Lincoln Electric Holdings (LECO) +11.1%, Revvity (RVTY) +4.1%, Thermo Fisher Scientific (TMO) +8.3%.

Which company is more profitable?

Thermo Fisher Scientific (TMO) has the highest net margin (Lincoln Electric Holdings (LECO) 12.4%, Revvity (RVTY) 8.2%, Thermo Fisher Scientific (TMO) 14.9%). On return on invested capital, Lincoln Electric Holdings (LECO) leads (Lincoln Electric Holdings (LECO) 22.6%, Revvity (RVTY) 3.1%, Thermo Fisher Scientific (TMO) 8.0%).

Which stock has performed better?

Over the past year Revvity (RVTY) returned the most: Lincoln Electric Holdings (LECO) +21.8%, Revvity (RVTY) +62.1%, Thermo Fisher Scientific (TMO) +20.3%. Over five years, Lincoln Electric Holdings (LECO) compounded fastest (Lincoln Electric Holdings (LECO) +15.1%/yr, Revvity (RVTY) -2.7%/yr, Thermo Fisher Scientific (TMO) +1.2%/yr). Returns are price only, before dividends.

Which pays a higher dividend?

Lincoln Electric Holdings (LECO) has the highest dividend yield: Lincoln Electric Holdings (LECO) 1.11%, Revvity (RVTY) 0.18%, Thermo Fisher Scientific (TMO) 0.27%.

Which stock is riskier?

By one-year price volatility, Thermo Fisher Scientific (TMO) has been the steadiest (Lincoln Electric Holdings (LECO) 31.1%, Revvity (RVTY) 40.1%, Thermo Fisher Scientific (TMO) 30.0%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, LECO, RVTY and TMO?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Lincoln Electric Holdings (LECO) leads on 7. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.